|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.65 USD | +2.29% |
|
+0.04% | +14.78% |
| 21/01 | Goldman Saschs Adjusts Mosaic Price Target to $32 From $30, Maintains Buy Rating | MT |
| 21/01 | Mosaic Extends Suspension of Phosphate Production in Brazil | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.67 | 7.84 | 13.2 | 3.45 | 1.69 | |||||
Return on Total Capital | 2.27 | 11.05 | 19.25 | 4.94 | 2.39 | |||||
Return On Equity % | 6.96 | 15.95 | 31.51 | 9.82 | 1.68 | |||||
Return on Common Equity | 7.1 | 16.16 | 31.62 | 9.57 | 1.47 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 12.27 | 26.17 | 30.21 | 16.14 | 13.59 | |||||
SG&A Margin | 4.28 | 3.48 | 2.6 | 3.65 | 4.47 | |||||
EBITDA Margin % | 15.64 | 28.08 | 30.39 | 17.07 | 15.81 | |||||
EBITA Margin % | 6.8 | 21.81 | 25.52 | 10.07 | 6.7 | |||||
EBIT Margin % | 6 | 21.22 | 25.09 | 9.35 | 5.59 | |||||
Income From Continuing Operations Margin % | 7.67 | 13.23 | 18.9 | 8.83 | 1.82 | |||||
Net Income Margin % | 7.67 | 13.2 | 18.73 | 8.51 | 1.57 | |||||
Net Avail. For Common Margin % | 7.67 | 13.2 | 18.73 | 8.51 | 1.57 | |||||
Normalized Net Income Margin | 1.31 | 12.02 | 16.01 | 6.02 | -1.21 | |||||
Levered Free Cash Flow Margin | 3.19 | 6.32 | 9.94 | 5.88 | 2.92 | |||||
Unlevered Free Cash Flow Margin | 4.73 | 7.31 | 10.49 | 6.74 | 3.89 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.44 | 0.59 | 0.84 | 0.59 | 0.48 | |||||
Fixed Assets Turnover | 0.73 | 1 | 1.5 | 1.03 | 0.81 | |||||
Receivables Turnover (Average Receivables) | 12.6 | 11.9 | 13.49 | 10.43 | 10.25 | |||||
Inventory Turnover (Average Inventory) | 3.99 | 4.07 | 4.25 | 3.79 | 3.79 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.12 | 1.11 | 1.18 | 1.22 | 1.08 | |||||
Quick Ratio | 0.52 | 0.51 | 0.47 | 0.49 | 0.39 | |||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.46 | 0.71 | 0.62 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 29.04 | 30.66 | 27.06 | 35 | 35.7 | |||||
Days Outstanding Inventory (Average Inventory) | 91.67 | 89.63 | 85.92 | 96.39 | 96.57 | |||||
Average Days Payable Outstanding | 71.14 | 61.52 | 52.21 | 62.96 | 59.36 | |||||
Cash Conversion Cycle (Average Days) | 49.57 | 58.77 | 60.77 | 68.43 | 72.91 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 48.71 | 40.99 | 31.23 | 32.13 | 38.31 | |||||
Total Debt / Total Capital | 32.75 | 29.07 | 23.8 | 24.32 | 27.7 | |||||
LT Debt/Equity | 42.88 | 32.06 | 20.89 | 27.34 | 30.25 | |||||
Long-Term Debt / Total Capital | 28.84 | 22.74 | 15.92 | 20.7 | 21.87 | |||||
Total Liabilities / Total Assets | 50.71 | 51.22 | 47.86 | 46.02 | 49.33 | |||||
EBIT / Interest Expense | 2.43 | 13.49 | 28.42 | 6.78 | 2.7 | |||||
EBITDA / Interest Expense | 7.4 | 18.95 | 35.84 | 13.7 | 8.82 | |||||
(EBITDA - Capex) / Interest Expense | 1.93 | 12.32 | 28.45 | 6.28 | 3.37 | |||||
Total Debt / EBITDA | 3 | 1.2 | 0.63 | 1.54 | 2.19 | |||||
Net Debt / EBITDA | 2.64 | 0.99 | 0.51 | 1.41 | 2.06 | |||||
Total Debt / (EBITDA - Capex) | 11.47 | 1.84 | 0.79 | 3.36 | 5.74 | |||||
Net Debt / (EBITDA - Capex) | 10.09 | 1.52 | 0.64 | 3.07 | 5.38 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.52 | 42.34 | 54.77 | -28.39 | -18.79 | |||||
Gross Profit, 1 Yr. Growth % | 18.68 | 206.27 | 78.64 | -61.59 | -31.61 | |||||
EBITDA, 1 Yr. Growth % | 2.36 | 173.25 | 66.33 | -59.7 | -24.79 | |||||
EBITA, 1 Yr. Growth % | 22.26 | 436.41 | 79.44 | -71.68 | -45.92 | |||||
EBIT, 1 Yr. Growth % | 25.47 | 505.24 | 81.23 | -73.23 | -51.49 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -161.02 | 145.63 | 121.07 | -66.54 | -83.29 | |||||
Net Income, 1 Yr. Growth % | -162.4 | 144.8 | 119.72 | -67.49 | -84.99 | |||||
Normalized Net Income, 1 Yr. Growth % | -21.55 | 2.42T | 103.81 | -72.94 | -116.29 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -162.92 | 144 | 135.6 | -65.21 | -84.37 | |||||
Accounts Receivable, 1 Yr. Growth % | 13.36 | 83.61 | 10.96 | -23.92 | -8.78 | |||||
Inventory, 1 Yr. Growth % | -16.24 | 57.62 | 29.24 | -28.79 | 1 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.22 | 4.72 | 2.11 | 7.42 | -1.76 | |||||
Total Assets, 1 Yr. Growth % | 2.55 | 11.35 | 6.12 | -1.51 | -0.47 | |||||
Tangible Book Value, 1 Yr. Growth % | 4.73 | 12.17 | 15.97 | 1.95 | -6.55 | |||||
Common Equity, 1 Yr. Growth % | 4.31 | 10.67 | 13.68 | 1.95 | -6.57 | |||||
Cash From Operations, 1 Yr. Growth % | 44.48 | 38.19 | 79.96 | -38.84 | -46.03 | |||||
Capital Expenditures, 1 Yr. Growth % | -7.99 | 10.08 | -3.21 | 12.43 | -10.74 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -1.2T | 252.42 | 138.5 | -57.47 | -60.69 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 273.48 | 153.94 | 118.46 | -53.81 | -53.2 | |||||
Dividend Per Share, 1 Yr. Growth % | 14.29 | 37.5 | 136.36 | 23.08 | 6.25 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.84 | 17.79 | 48.42 | 5.28 | -23.74 | |||||
Gross Profit, 2 Yr. CAGR % | -15.7 | 89.84 | 132.92 | -16.89 | -48.75 | |||||
EBITDA, 2 Yr. CAGR % | -15.98 | 61.61 | 115.69 | -18.4 | -44.95 | |||||
EBITA, 2 Yr. CAGR % | -24.84 | 144.47 | 218.19 | -28.53 | -60.86 | |||||
EBIT, 2 Yr. CAGR % | -27.49 | 161.51 | 240.87 | -30.16 | -63.96 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 19.02 | 22.43 | 133.02 | -14 | -76.36 | |||||
Net Income, 2 Yr. CAGR % | 19.05 | 23.6 | 131.92 | -15.48 | -77.91 | |||||
Normalized Net Income, 2 Yr. CAGR % | -45.36 | 244.55 | 646.67 | -25.59 | -78.82 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 19.77 | 23.91 | 139.76 | -9.46 | -76.68 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.09 | 44.27 | 42.73 | -8.12 | -16.69 | |||||
Inventory, 2 Yr. CAGR % | -12.47 | 14.9 | 42.73 | -4.06 | -15.19 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.19 | 2.96 | 3.41 | 4.73 | 2.73 | |||||
Total Assets, 2 Yr. CAGR % | -0.82 | 6.86 | 8.71 | 2.24 | -0.99 | |||||
Tangible Book Value, 2 Yr. CAGR % | -1.63 | 8.39 | 14.06 | 8.73 | -2.39 | |||||
Common Equity, 2 Yr. CAGR % | -4 | 7.44 | 12.17 | 7.66 | -2.4 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.95 | 41.3 | 57.7 | 4.91 | -42.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | 10.74 | 0.64 | 3.22 | 4.32 | 0.18 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -8.15 | 740 | 201.59 | -0.98 | -58.65 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -5.83 | 169.92 | 141.94 | -1.03 | -53.5 | |||||
Dividend Per Share, 2 Yr. CAGR % | 41.42 | 25.36 | 80.28 | 70.56 | 14.35 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.42 | 8.83 | 29.01 | 16.41 | -3.45 | |||||
Gross Profit, 3 Yr. CAGR % | 8.11 | 29.23 | 86.03 | 27.57 | -22.12 | |||||
EBITDA, 3 Yr. CAGR % | 6.27 | 21.73 | 63.56 | 23.22 | -20.59 | |||||
EBITA, 3 Yr. CAGR % | 7.75 | 37.13 | 121.21 | 41.95 | -34.87 | |||||
EBIT, 3 Yr. CAGR % | 5.79 | 38.29 | 132.16 | 45.85 | -38.15 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 85.54 | 51.53 | 49.08 | 22.02 | -50.19 | |||||
Net Income, 3 Yr. CAGR % | 83.84 | 51.39 | 49.73 | 20.48 | -52.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | -20.34 | 57.34 | 190.33 | 146.7 | -55.16 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 78.06 | 51.83 | 53.51 | 25.99 | -49.59 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.26 | 24.15 | 32.18 | 15.73 | -8.34 | |||||
Inventory, 3 Yr. CAGR % | 3.98 | 6.49 | 19.5 | 13.21 | -2.4 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.39 | 2.35 | 2.67 | 4.73 | 2.52 | |||||
Total Assets, 3 Yr. CAGR % | 2.03 | 3.08 | 6.61 | 5.19 | 1.32 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2 | 2.77 | 10.86 | 9.87 | 3.38 | |||||
Common Equity, 3 Yr. CAGR % | -0.13 | 0.66 | 9.48 | 8.65 | 2.69 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.15 | 15.76 | 53.16 | 15 | -15.94 | |||||
Capital Expenditures, 3 Yr. CAGR % | 12.59 | 10.52 | -0.66 | 6.21 | -0.96 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6 | 33.55 | 455.8 | 56.76 | -26.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.55 | 24.94 | 153.01 | 39.14 | -22.89 | |||||
Dividend Per Share, 3 Yr. CAGR % | -30.66 | 40.1 | 54.87 | 58.74 | 45.67 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.48 | 11.52 | 20.88 | 7.39 | 4.54 | |||||
Gross Profit, 5 Yr. CAGR % | -9.12 | 31.9 | 46.96 | 8.09 | 11 | |||||
EBITDA, 5 Yr. CAGR % | -8.25 | 23.62 | 38.73 | 3.98 | 5.76 | |||||
EBITA, 5 Yr. CAGR % | -15.33 | 40.18 | 59.56 | 5.7 | 10.59 | |||||
EBIT, 5 Yr. CAGR % | -16.91 | 42.26 | 61.24 | 5.26 | 10.14 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -7.85 | 40.26 | 103.25 | 20.81 | -28.63 | |||||
Net Income, 5 Yr. CAGR % | -7.81 | 40.5 | 101.75 | 19.91 | -30.35 | |||||
Normalized Net Income, 5 Yr. CAGR % | -30.75 | 46.23 | 68.54 | 16.68 | 1.42 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -8.84 | 38.11 | 100.56 | 23.46 | -27.77 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.28 | 18.32 | 21.59 | 10.07 | 9.9 | |||||
Inventory, 5 Yr. CAGR % | 2.15 | 14.53 | 18.02 | 2.14 | 4.18 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.64 | 6.49 | 5.78 | 3.3 | 2.7 | |||||
Total Assets, 5 Yr. CAGR % | 2.62 | 5.53 | 4.65 | 2.74 | 3.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.16 | 3.47 | 6.66 | 5.12 | 5.36 | |||||
Common Equity, 5 Yr. CAGR % | 0.1 | 2.04 | 4.62 | 3.4 | 4.56 | |||||
Cash From Operations, 5 Yr. CAGR % | -4.94 | 11.66 | 33.29 | 11.29 | 3.47 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.19 | 8.85 | 8.75 | 8 | -0.32 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -22.09 | 60.67 | 52.26 | 19.68 | 96.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -17.09 | 41.2 | 42.68 | 14.81 | 28.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | -28.56 | -24.21 | 1.61 | 51.57 | 37.18 |
- Stock Market
- Equities
- MOS Stock
- Financials The Mosaic Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















